Barclays’ loan book is in the final stages of an extreme stress test by City regulators as it considers whether to meet the March 31 deadline to apply for the government’s insurance scheme, which ringfences toxic assets. The FSA watchdog will shortly conclude its trawl  of Barclays’ books and has indicated the bank does not require fresh capital. But some analysts say it might need a large capital injection, even though it is close to the sale of iShares, its asset management business that could fetch up to $6.5bn.

This entry was posted by Gwen Robinson on Friday, March 27th, 2009 at 4:59 and is filed under Capital markets. Tagged with barclays, ishares. Edit this entry.